Rochelle Stenzler

Rochelle served as Chair of the Board of publicly traded (TSX & NASDAQ) Cynapsus Therapeutics Inc., until it was acquired for C$841 million by Sunovion Pharmaceuticals Inc. in late 2016. She is currently the Chair of Spartan Bioscience Inc. and recently concluded a 9 year term where she served as a Board Director & Vice Chair of the Humber River Hospital in Toronto, Canada. Rochelle has extensive experience as a senior executive in retailing, consumer packaged goods, IVR technology & health care services, having held a variety of executive leadership roles including President of Revlon Canada Inc. and President & General Manager of Pharma Plus Drugmarts Ltd.